Brookfield Corp (BN)vsHelius Medical Technologies Inc Class A (HSDT)
BN
Brookfield Corp
$38.22
+0.45%
FINANCIAL SERVICES · Cap: $85.32B
HSDT
Helius Medical Technologies Inc Class A
$2.22
+3.26%
FINANCIAL SERVICES · Cap: $125.75M
Smart Verdict
WallStSmart Research — data-driven comparison
Brookfield Corp generates 668323% more annual revenue ($80.69B vs $12.07M). BN leads profitability with a 1.8% profit margin vs 0.0%. HSDT trades at a lower P/E of 0.0x. BN earns a higher WallStSmart Score of 63/100 (C+).
BN
Buy63
out of 100
Grade: C+
HSDT
Avoid34
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Reasonable price relative to book value
Strong operational efficiency at 25.7%
Earnings expanding 40.3% YoY
Attractively priced relative to earnings
Reasonable price relative to book value
Revenue surging 5774.0% year-over-year
Safe zone — low bankruptcy risk
Areas to Watch
ROE of 3.0% — below average capital efficiency
1.8% margin — thin
Premium valuation, high expectations priced in
Negative free cash flow — burning cash
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -137.4% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : BN
The strongest argument for BN centers on Market Cap, Price/Book, Operating Margin. PEG of 1.27 suggests the stock is reasonably priced for its growth.
Bull Case : HSDT
The strongest argument for HSDT centers on P/E Ratio, Price/Book, Revenue Growth. Revenue growth of 5774.0% demonstrates continued momentum.
Bear Case : BN
The primary concerns for BN are Return on Equity, Profit Margin, P/E Ratio. A P/E of 70.8x leaves little room for execution misses. Debt-to-equity of 5.69 is elevated, increasing financial risk.
Bear Case : HSDT
The primary concerns for HSDT are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
BN profiles as a value stock while HSDT is a hypergrowth play — different risk/reward profiles.
BN carries more volatility with a beta of 1.82 — expect wider price swings.
HSDT is growing revenue faster at 5774.0% — sustainability is the question.
HSDT generates stronger free cash flow (-12M), providing more financial flexibility.
Bottom Line
BN scores higher overall (63/100 vs 34/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Brookfield Corp
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Brookfield Corporation is an alternative asset manager and REIT/Real Estate Investment Manager firm focuses on real estate, renewable power, infrastructure and venture capital and private equity assets. The company is headquartered in Toronto, Canada with additional offices across Northern America; South America; Europe; Middle East and Asia.
Helius Medical Technologies Inc Class A
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing and acquiring non-invasive technologies for the treatment of symptoms caused by neurological diseases or trauma. The company is headquartered in Newtown, Pennsylvania.
Compare with Other ASSET MANAGEMENT Stocks
Want to dig deeper into these stocks?